风险因子修改在心房的作用:导管切除的结果
Shahana Hussain1, Neil Srinivasan2,3, Syed Ahsan1
1Electrophysiology Department, Barts Heart Centre, St Bartholomew's Hospital, London EC1A 7BE, UK.
Journal of cardiovascular development and disease
|April 26, 2024
概括
改变生活方式对于管理心房动 (AF) 和改善导管切除成功至关重要. 解决可修改的风险因素现在是关键的指导方针,提高治疗结果,促进无心律失常的生存.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 预防医学 预防医学
背景情况:
- 心房动 (AF) 的管理已经通过医疗和导管切除技术取得了进展.
- 这些治疗方法在单独使用时表现出有限的成功.
- 可修改的风险因素越来越多地被认为是AF发展,传播和治疗失败的重要因素.
研究的目的:
- 突出生活方式修改在AF管理中的演变作用.
- 强调将生活方式干预措施纳入国际AF指导方针,特别是持久性AF.
- 为了强调在导管切除之前风险因素修改的重要性.
主要方法:
- 审查心房的管理当前的趋势和指导方针.
- 分析生活方式改变对AF的影响.
- 评估风险因素修改与导管切除相结合的作用.
主要成果:
- 生活方式的修改现在被整合到AF管理指南中.
- 解决可修改的风险因素对于成功治疗AF至关重要.
- 有效的风险因素修改改善了导管切除后的结果.
结论:
- 生活方式干预对于全面的心房动管理至关重要.
- 优先考虑风险因素修改可以提高导管切除的疗效.
- 综合管理策略改善了AF患者无心律失常的生存率.
相关概念视频
Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


